Radiotherapy & Oncology
Volume 86, Issue 1 , Pages 14-19 , January 2008

Antiproton radiotherapy

  • Niels Bassler

      Affiliations

    • Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    • Deutsches Krebsforschungszentrum, Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Niels Bassler, Deutsches Krebsforschungszentrum, E0409, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
    • ,
  • Jan Alsner

      Affiliations

    • Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Gerd Beyer

      Affiliations

    • Hospital Universitaire de Geneve, Geneva, Switzerland
    • ,
  • John J. DeMarco

      Affiliations

    • David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    • ,
  • Michael Doser

      Affiliations

    • CERN, Geneva, Switzerland
    • ,
  • Dragan Hajdukovic

      Affiliations

    • University of Montenegro, Podgorica, Montenegro
    • ,
  • Oliver Hartley

      Affiliations

    • Hospital Universitaire de Geneve, Geneva, Switzerland
    • ,
  • Keisuke S. Iwamoto

      Affiliations

    • David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    • ,
  • Oliver Jäkel

      Affiliations

    • Deutsches Krebsforschungszentrum, Heidelberg, Germany
    • ,
  • Helge V. Knudsen

      Affiliations

    • Department of Physics and Astronomy, and
    • ,
  • Sandra Kovacevic

      Affiliations

    • University of Montenegro, Podgorica, Montenegro
    • ,
  • Søren Pape Møller

      Affiliations

    • ISA, University of Aarhus, Aarhus, Denmark
    • ,
  • Jens Overgaard

      Affiliations

    • Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Jørgen B. Petersen

      Affiliations

    • Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Timothy D. Solberg

      Affiliations

    • University of Nebraska Medical Center, Omaha, NE, USA
    • ,
  • Brita S. Sørensen

      Affiliations

    • Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Sanja Vranjes

      Affiliations

    • VINCA Institute for Nuclear Sciences, Belgrade, Serbia
    • ,
  • Bradly G. Wouters

      Affiliations

    • University of Maastricht, Res. Institute Growth and Development, The Netherlands
    • ,
  • Michael H. Holzscheiter

      Affiliations

    • University of New Mexico, Albuquerque, NM, USA

Received 24 September 2007 ,Revised 13 November 2007 ,Accepted 28 November 2007.

References 

  1. Gray L, Kalogeropoulos TE. Possible biomedical applications of antiproton beams: focused radiation transfer. Radiat Res. 1984;246–252
  2. Sullivan AH. A measurement of the local energy deposition by antiprotons coming to rest in tissue-like material. Phys Med Biol. 1985;30:1297–1303
  3. Goitein Michael, Goitein Gudrun. Swedish protons. Acta Oncologica. 2005;44:793–797
  4. Olsen Dag Rune, Bruland Øjvind S, Frykholm Gunilla, Norderhaug Inger Natvig. Proton therapy – A systematic review of clinical effectiveness. Radiother Oncol. 2007;83:123–132
  5. Jäkel O, Schulz-Ertner D, Karger CP, Nikoghosyan A, Debus J. Heavy ion therapy: status and perspectives. Technol Cancer Res Treat. 2003;2:377–387
  6. Schulz-Ertner Daniela, Jäkel Oliver, Schlegel Wolfgang. Radiation therapy with charged particles. Semin Radiat Oncol. 2006;16:249–259
  7. Schulz-Ertner Daniela, Tsujii Hirohiko. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25:953–964
  8. Budach V. The role of fast neutrons in radiooncology – A critical appraisal. Strahlenther Onkol. 1991;167:677–692
  9. Wisser L. Pion treatment of prostate carcinoma at Paul Scherrer Institute (formerly Swiss Institute for Nuclear Research (SIN)) from 1983 to 1992. Cancer Radiothérapie. 2004;8:88–94
  10. Bassler N, Holzscheiter M, Knudsen H, The AD4/ACE Collaboration. Cancer therapy with antiprotons. In: Dieter Grzonka, Rafał Czyżykiewicz, Walter Oelert, Thomasz Rożek, Peter Winter, editors. Low Energy Antiproton Physics-LEAP ’05, vol. CP796 of AIP Conference Proceedings. American Institute of Physics, 2005; pp. 423–430.
  11. Ponomarev LI. Molecular structure effects on atomic and nuclera capture of mesons. Annu Rev Nucl Sci. 1973;395–430
  12. Agnew Lewis E, Elioff Tom, Fowler William B, Lander Richard L, Powell Wilson M, Segrè Emilio, et al. Antiproton interactions in hydrogen and carbon below 200MeV. Phys Rev. 1960;1371–1391
  13. Inokuti M. Interactions of antiprotons with atoms and molecules. Nucl Tracks Radiat Meas. 1989;16:115–123
  14. Cugnon J, Wycech S, Jastrze¸bski J, Lubiński P. Geometrical effects in antiproton annihilation on nuclei. Phys Rev C. 2001;63:027301
  15. Markiel W, Daniel H, von Egidy T, Hartmann FJ, Hofmann P, Kanert W, et al. Emission of helium ions after antiproton annihiliation in nuclei. Nuclear Physics A. 1988;485:445–460
  16. Polster D, Hilscher D, Rossner H, von Egidy T, Harmann FJ, Hoffmann J, et al. Light particle emission induced by stopped antiprotons in nuclei: energy dissipation and neutron-to-proton ratio. Phys Rev C. 1995;51:1167–1180
  17. Holzscheiter Michael H, Bassler Niels, Agazaryan Nzhde, Beyer Gerd, Blackmore Ewart, DeMarco John J, et al. The biological effectiveness of antiproton irradiation. Radiother Oncol. 2006;81:233–242
  18. Fassò A, Ferrari A, Ranft J, Sala PR. FLUKA: a multi-particle transport code. CERN-2005-10, INFN/TC_05/11, SLAC-R-773.
  19. The physics models of FLUKA: status and recent developments, La Jolla, CA, USA, 2003. (paper MOMT005), eConf C0303241 (2003), arXiv:hep-ph/0306267.
  20. Hansen JW, Olsen KJ, Wille M. The alanine radiation detector for high and low LET dosimetry. Radiat Prot Dosimetry. 1987;19:43–47
  21. Palmans H. Effect of alanine energy response and phantom material on depth dose measurements in ocular protons beams. Technol Cancer Res Treat. 2003;2:579–586
  22. Niels Bassler. Experimental studies relevant for antiproton cancer therapy. Ph.D. thesis, Aarhus University, 2006.
  23. Boag JW, Currant J. Current collection and ionic recombination in small cylindrical ionization chambers exposed to pulsed radiation. Brit J Radiol. 1980;53:471–478
  24. Kanai Tatsuaki, Sudo Michio, Matsufujii Naruhiro, Futami Yasuyuki. Initial recombination in a parallel-plate ionization chamber exposed to heavy ions. Phys Med Biol. 1998;43:3549–3558
  25. Gudowska Irena, Sobolevsky Nikolai, Andreo Pedro, Belkic` Dževad, Brahme Anders. Ion beam transport in tissue-like media using the monte carlo code SHIELD-HIT. Phys Med Biol. 2004;49:1933–1958
  26. Krämer M, Jäkel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy physical beam model and dose optimization. Phys Med Biol. 2000;45:3299–3317
  27. Krämer M, Scholz M. Treatment planning for heavy-ion radiotherapy calculation and optimization of biologically effective dose. Phys Med Biol. 2000;45:3319–3330
  28. Scholz M. Grundlagen der biologischen Bestrahlungsplanung fur die Schwerionen-Tumortherapie. Medizinische Fakultat Heidelberg, Ruprecht-Karls-Universität. Habilitationsschrift. (In German).
  29. Scholz M, Kraft G. Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res. 1995;18:5–14
  30. Scholz M, Kellerer AM, Kraft-Weyrather W. Computation of cell survival in heavy ion beams for therapy. Radiat Environ Biophys. 1997;36:59–66

PII: S0167-8140(07)00634-2

doi: 10.1016/j.radonc.2007.11.028

Radiotherapy & Oncology
Volume 86, Issue 1 , Pages 14-19 , January 2008

Article Tools

* Image Usage & Resolution